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Abstract
Background: Quorum sensing inhibitionis an advanced strategy that aims to interfere with bacterial cell-to-cell communica-
tion systems (quorum sensing), which regulate virulence factors production in Pseudomonas aeruginosa, in order to overcome the 
globalcrisis of  antimicrobial resistance.
Objectives: Study the potential quorum sensing inhibitory effect of  Zinc oxide (ZnO)nanoparticlesin Pseudomonas aeruginosa and 
the impact on production of  virulence factors. 
Methods: Quorum sensing inhibitory effect of  ZnO was evaluated by assessing its ability to reducePseudomonas aeruginosa 
virulence factors production; rhamnolipids, pyocyanin, pyoverdin, hemolysins, elastase and proteases. Furthermore, qRT-PCR 
was performed to determine ZnO inhibitory effect onQS-regulatory geneslasI, lasR,rhlI, rhlR, pqsA and pqsR that control 
virulence factors secretion. Moreover, mice survival test was conducted to investigate the influence of  ZnO on Pseudomonas 
aeruginosa-induced mortality in vivo. 
Results: ZnO revealed a statistically significant reduction in the production of  QS-controlled virulence factors rhamnolipids, 
pyocyanin, pyoverdin, hemolysins, elastase and proteases. Furthermore, ZnO exhibited a significant decrease in the relative ex-
pression of  QS-regulatory geneslasI, lasR,rhlI, rhlR,pqsA and pqsR. Additionally, ZnO significantly reduced the pathogenesis 
of  Pseudomonas aeruginosa in vivo
Conclusion: ZnO nanoparticles can be used as a quorum sensing inhibitor in Pseudomonas aeruginosa infections either as an adju-
vant or alternative to conventional antimicrobials.
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Pseudomonas aeruginosa (Ps. aeruginosa) is considered one of  
the most frequent opportunistic pathogens worldwide 
that can infect patients with severe medical conditions, 
particularly immunosuppressed patients. It is responsi-
ble for many nosocomial diseases including respiratory 
tract infections, urinary tract infections,burn and surgical 
wound infections1. The fast expansion of  bacterial resis-
tance to antibioticsmakes it urgent to discover new thera-
peutic agents in order to combat this issue2. 
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In Ps. aeruginosa, bacterial cells communicatewith each 
other through a process known as quorum sensing (QS)
which plays a major role in bacterial pathogenesis3. In 
Ps. aeruginosa, there are three major QS systems, lasI/R 
system, rhlI/R system and pqsA/R system which are in-
terconnected together through signaling chemical mole-
cules (autoinducers); oxododecanoyl-homoserine lactone 
(C12-HSL), butyryl-homoserine lactone (C4-HSL) and 
Pseudomonas quinolone-based intracellular signal (PQS)
produced by bacterial cells. When chemical autoinducers 
reach a certain threshold, the quorum, they trigger the 
genes that regulate the production of  virulence factors-
such as pyocyanin, pyoverdin, hemolysins, elastase and 
proteases4-6.
Quorum sensing inhibitors are agents that disrupt QS 
systems in bacterial cells leading to a reduction of  vir-
ulence factors production and suppression of  virulence 
without interrupting the bacterial growth and so no or 
low resistance is anticipated to arise against these agents7.
In the recent years, the advances accomplished in the 
field of  nanotechnology resulted in an increase in the ap-
plications of  nanoparticles in the medical sector andas a 
therapy for infectious diseases. Superior effectiveness on 
resistant strains of  metal oxide nanoparticles such as Zinc 
oxide (ZnO) and silver has been reported. ZnO nanopar-
ticles were found to exert a potent antimicrobial activity 
and significantly reduced skin infections and inflamma-
tion in mice8-9.
The current study aimed to investigate the possible quo-
rum sensing inhibiting activity of  ZnO nanoparticles and 
their potential role in reducing QS-controlled virulence 
factors production and pathogenesis in Ps. aeruginosa.
Materials and methods
Bacterial isolates and their identification
Ps.aeruginosa PAO1 wild-type standard strain and five 
clinical isolates(Ps1, Ps2, Ps3, Ps4 and Ps5) were used 
in this study. Ps.aeruginosa PAO1 was provided from the 
stock culture collection of  Microbiology and Immunol-
ogy Department, Faculty of  Pharmacy, Zagazig Uni-
versity. Clinical isolates were isolated from patients with 
burn and surgical wound infections admitted to Port Said 
General Hospital, Egypt. Clinical isolates were identified 
by Gram-stain, production of  green pigmentson nutrient 
agar, growth on MacConkey agar, oxidase test, motility, 
growth on selective mediumcetrimide agar and the ability 
to grow at 42°C as stated by Koneman et al10.
Media and chemicals
Mueller-Hinton broth, nutrient agar, MacConkey agar, 
cetrimide agar, tryptone and yeast extract were purchased 
from (Oxoid, UK), ZnO nanoparticles, Tris-base an-
dElastin Congo Red (ECR) from (Sigma, St. Louis, USA). 
Other chemicals were of  pharmaceutical grade.
Antibiotic susceptibility testing of  the clinical iso-
lates 
The antibiotic susceptibility testing for the clinical isolates 
was carried out using the disc diffusion technique as de-
scribed by the Clinical Laboratory and Standards Institute 
(CLSI)11 against 10 anti-pseudomonal antibiotics includ-
ing, aztreonam 30 µg (ATM), piperacillin 100 µg (PRL), 
ceftazidime 30 µg (CAZ), cefepime 30 µg (FEP), cipro-
floxacin  5  µg  (CIP),  levofloxacin  5  µg  (LEV), amika-
cin 30 µg (AK), gentamicin 10 µg (CN), colistin sulfate 10 
µg (CT) and imipenem 10 µg (IPM). The anti-pseudomo-
nal discs were purchased from (Oxoid, UK).
Determination of  minimum inhibitory concentra-
tion and investigating the effect of  sub-inhibitory 
concentration of  ZnO nanoparticles on bacterial 
growth
The minimum inhibitory concentration (MIC) of  ZnO 
nanoparticles was determinedby using the agar dilution 
method according to(CLSI)11. Briefly, overnight bacteri-
al cultures of  the tested isolateswere diluted, each with 
Mueller-Hinton broth to reach a turbidity matching that 
of  0.5 MacFarland Standard and then with sterile saline 
to achieve a final concentration of  107 CFU/ml. Nutrient 
agar plates with different concentrations of  ZnO (1, 2,4, 
8, 16, 32 and 64mg/ml) were prepared in addition to con-
trol plates without ZnO. The plates' surfaces were inoc-
ulated with 1µl of  the suspensions of  the tested isolates 
and incubated overnight at 37°C. The MIC was calculated 
as the least concentration of  ZnO that prevented the visi-
ble growth of  bacteria.
To ensure that ZnO sub-MIC that would be used in fur-
ther experiments had no influence on bacterial viability, 
the effect of  ¼ MIC of  ZnO on bacterial growth was as-
sessed following Nalca et al12. The tested isolates were in-
cubated in Luria-Bertani (LB) broth (tryptone 10 g, yeast 
extract 5g and 10 g sodium chloride in 1000 ml distilled 
H2O) with and without ¼ MIC of  ZnO under the same 
conditions. After 24h of  incubation at 37°C, the optical 
densities of  ZnO-treated and untreated cultures were 
African Health Sciences Vol 19 Issue 2, June, 2019 2044
measured at OD600 using spectrofluorometer (Biotek, 
USA).
The phenotypic effect of  ZnO nanoparticles on QS-con-
trolled virulence factors production 
Effect on rhamnolipids 
Rhamnolipids production, in the presence and absence 
of  ZnO, was assessed by oil spreading method according 
to Morikawa et al13. A thin oily layer was formed on the 
surface of  water by addition of  20µl of  crude oil to 15 
ml of  distilled H2O in a Petri dish. Ten µl of  cell-free 
supernatants of  the tested isolates with and without ¼ 
MIC of  ZnO was added to the center of  the oily layer. 
The diameters of  the clear zones formed that are related 
to the biosurfactant activity and the amounts of  rhamno-
lipids produced by the tested isolates were measured and 
compared. 
Effect on pyocyanin
Pyocyanin determination was performed in King A me-
dium (peptone 20 g, MgCl2 1.4 g and 10 g K2SO4 in 1000 
ml distilled H2O)according to Essar et al
14. The tested iso-
lates were grown in King A mediumwith and without¼ 
MIC of  ZnO for 48 h at 37° C. Pyocyanin was extracted 
by addition of  aliquots of  2.5 ml of  bacterial superna-
tants to 3 ml chloroform followed by mixing with 1 ml 
of  0.2 N HCl. The pigment in chloroform layer was mea-
sured at OD520 using spectrofluorometer (Biotek, USA).
Effect on pyoverdin 
In order to estimate pyoverdin, the method of  Coxan-
dAdams15 was used. Overnight cultures of  the tested iso-
latesin LB broth were prepared in the presence and ab-
sence of  ¼ MIC of  ZnO and then centrifuged at 10000 
rpm for 10 min. The cell-free supernatants were diluted 
to 1/10 with 50 mM Tris-HCl and pH adjusted to 7.4. 
The pyoverdin fluorescence in supernatants was mea-
sured at 460 nm,where the samples were excited at 400 
nm using spectrofluorometer (Biotek, USA). 
Effect on hemolysins 
Production of  hemolysin was determined following the 
modified method ofDacheux et al16. Aliquots of  0.5 ml of  
cell-free supernatants of  tested isolates in LB broth with 
and without ¼ MIC of  ZnO were mixed with 0.7 ml of  
2% sheep RBCs in saline followed by incubation at 37°C 
for 2 h. After centrifugation of  assay mixtures at 2500 
rpm for 5 min to remove any cells, the released hemo-
globin was measured at OD540 nm. Percentage lysis was 
calculated from the formula: [X-B/T-B]x 100, where B is 
the negative control corresponding to RBCs in LB broth, 
T is the positive control corresponding to completely 
lysed RBCs with 0.1%SDS and X is the ZnO-treated or 
untreated isolates. The hemolytic activity percentage pro-
duced byZnO-treated isolates was compared to that pro-
duced by untreated isolates.
Effect on elastase
Elastase assay was evaluated according to Ohman et al17 
using ECR. Briefly, an aliquot of  0.5 ml of  ECR solu-
tion (10 mg/ml) in Tris buffer (pH 7.0) was inoculated 
with 0.25ml of  each cell-free supernatant of  the tested 
isolates prepared in the presence and absence of  ¼ MIC 
of  ZnO. The mixtures were left at 37°C for 6 h and then 
centrifuged at 10000 rpm for 10 min to remove insolu-
ble ECR pellets. The color of  released ECR in superna-
tantswas measured at OD495 nm using spectrofluorom-
eter(Biotek, USA).
Effect on proteases 
The total proteases were estimated by the modified skim 
milk assayas described by El-Mowafy et al18. An aliquot of  
0.5 ml cell-free supernatant of  each of  the testedisolates 
prepared with and without ¼ MIC of  ZnOwasmixed 
with 1 ml of  skim milk solution (1.25% in distilled H2O) 
and incubated at 37°C for 30 minutes. The turbidities of  
assay mixtures were measured at OD600using spectroflu-
orometer as a measure of  the proteolytic activity.
Estimation of  relative gene expression of  QS-regu-
latory genes using qRT-PCR
For molecular determination of  QS-regulatory genes,-
total bacterial RNA was extracted at the middle of  the 
log phase,corresponding to OD600of  0.5-0.6,from the 
tested strains cultivated overnight in LB broth at 37°C 
in presence and absence of  ¼ MIC of  ZnO using Gene-
JET RNA Purification Kit following the manufacturer in-
structions.Reverse transcription followed by qRT-PCR of  
QS-regulatory genes lasI, lasR, rhlI, rhlR, pqsA and pqsR 
was carried out using SensiFAST™ SYBR® Hi-ROX 
One-Step Kit.StepOne Real-Time PCR thermal cycler 
utilizing primers illustrated in Table 1 was used to setup 
the qRT-PCR analysis. The relative expression values of  
QS-regulatory genes were normalized to the housekeep-
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ing gene rpoD and agarose gel electrophoresis was used 
to confirm the specific PCR amplification. The relative 
gene expression in ZnO-treatedcultures was compared 
to their expression levels in untreated ones following the 
2-∆∆Ct method19.
Mice survival test
The influence of  ZnO on Ps. aeruginosa pathogenesis was 
assessed by the mice survival in vivo model following the 
method of  Kim et al20. The ethical standards of  Medi-
cal Research Center, Ain Shams University, Cairo, Egypt, 
where the experiment was conducted and the mice 
were provided, were followed in the animal study. An 
approximate cell density of  2.5 x 107 CFU/ml in phos-
phate-buffered saline (PBS) of  Ps. aeruginosa PAO1 was 
prepared from overnight bacterial cultures in LB broth 
with and without ¼ MIC of  ZnO. Four random groups 
of  three-weeks-old healthy female albino mice (Mus mus-
culus) with the same weight were used, each comprising 
10 mice. In Group 1,mice were injected intraperitoneally-
with 100 µl of  ZnO-treated bacteria in sterile PBS, while 
group 2 was injected with 100 µl of  untreated bacteria. 
Two negative control groups are included also;group 3 
miceare injected with 100 µl of  sterile PBS andgroup 4 
mice were left uninoculated. All groups were kept with 
normal feeding and aeration at room temperature. The 
survival of  mice in each group was recorded every day 
for 3 successive days.The results were calculated using 
Log-rank test,GraphPad Prism 5 and plotted using Ka-
plan-Meier method.
Statistical analysis 
The influence of  ZnO on Ps. aeruginosa QS-controlled 
virulence factors production was analyzed using Graph-
Pad Prism 5 software package with One Way ANOVA 
according to Dunnet's or Tukey's Multiple Comparison 
Tests   < 0.05 or P < 0.001 for significance. Results were 
calculated as the means ± standard errors of  three bio-
logical experiments with three technical replicates each.
Results
Identification of  clinical isolates 
Ps. aeruginosa clinical isolates were identified from the 
following characters: they were Gram-negative rods and 
grew as non-lactose fermenters on MacConkey agar, they 
grew on cetrimide agar at 42°C and showed green pig-
mentation on nutrient agar, they were motile and oxidase 
positive. 
   Table 1 Primers used in qRT-PCR (El-Mowafy et al18). 




































a= Forward, b= Reverse 
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Antibiotic susceptibility and resistance pattern of  
clinical isolates
The tested clinical isolates of  P s. aeruginos ashowed high 
resistance against the various antibiotics used in this study. 
They all were found to be multi-drug resistant (MDR). 
The full results of  antibiotic susceptibility test are illus-
trated in Table 2.
Table 2 Antibiotic susceptibility pattern of the five clinical isolates 
Antibiotics 
Isolate No. 
ATM PRL CAZ FEP CIP LEV AK CN CT IPM 
  Ps1 S I R R R R R R R R 
Ps2 I R S R R R R R R R 
Ps3 R R R R R R R R S R 
Ps4 R R I R R R R R S R 
 Ps5 R R R R S S R R R R 
 
Antibacterial activity of  ZnO and growth inhibition 
assay
ZnO prevented the growth of  tested Ps. aeruginosa isolates 
at a concentration of  8 mg/ml and ¼ MIC (2mg/ml) was 
selected to test the effect of  ZnO against QS-controlled 
virulence factors.
The efficacy of  ZnO on QS-controlled virulence factors 
could be due to its effect on the growth of  Pseudomonas 
isolates. To exclude this possibility, the effect of  ¼ MIC 
of  ZnO on bacterial growth was assessed by measuring 
the optical density of  overnight culturesin LB broth at 
600 nm and no statistically significant difference in the 






















































































Figure 1. The OD600 of Ps.aeruginosa isolates was measured after overnight incubation  
in LB broth with and without ¼ MIC of ZnO. No significant difference was  
observed in the growth rates of ZnO-treated and untreated isolates. 
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ZnO inhibits rhamnolipids and pyocyanin produc-
tion 
ZnO could significantly reduce rhamnolipids produc-
tion from 100% in untreated isolates to 30%, 28%, 22%, 
35%, 21% and 31% in PAO-1, Ps1, Ps2, Ps3, Ps4 and Ps5 
ZnO-treated isolates respectively (Fig. 2a); while pyocy-
anin production was significantly decreased to 26%, 42%, 
33%, 33%, 47% and 27% in PAO-1, Ps1, Ps2, Ps3, Ps4 
and Ps5 ZnO-treated isolates respectively (Fig. 2b).
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Figure 2.(a) Rhamnolipids production reduction in ZnO-treated bacteria. The diameters of clear zones produced 
by addition of the supernatants obtained after culturing in LB broth in the presence and absence of¼ MIC of 
ZnO were measured. (b) Pyocyanin production reduction in ZnO-treated bacteria. The absorbance of pyocyanin 
was measured at 520 nm in the supernatants obtained from the cultures in King A broth in the presence and 
absence of¼ MIC of ZnO. The data shown represent the means ± standard errors of three biological experiments 
with three technical replicates each. *, significant P< 0.05. 
ZnO inhibits pyoverdin and hemolysins production
ZnO-treated cultures showed a remarkable decrease in 
pyoverdin production to 25%, 82%, 33%, 31%, 9% and 
28% in PAO-1, Ps1, Ps2, Ps3, Ps4 and Ps5 ZnO-treated 
isolates respectively (Fig. 3a). Furthermore, hemolysins 
production was completely blocked in PAO-1 and Ps4 
(0%) and was decreased tomerely 3%, 3%, 6% and 2% in 
Ps1, Ps2, Ps3 and Ps5 ZnO-treated isolates respectively 
(Fig. 3b).


























































































































































Figure 3.(a) Pyoverdin production reduction in ZnO-treated isolates. Pyoverdinfluorescence was measured at 
460 nm while the samples were excited at 400 nmafter overnight culture in LB broth in the presence and absence 
of¼ MIC of ZnO.(b) Hemolysin reduction in ZnO-treated isolates. Absorbance of hemoglobin red color released 
by hemolysisofRBCs was measured at 540 nm.The data shown are the means ± standard errors of three 
biological experiments with three technical replicates each. *, significant P< 0.05. 
ZnO inhibits elastase and proteases production 
Elastase production in the presence of  ZnO was sig-
nificantly diminished to 40%, 53%, 82%, 63%, 57% and 
48% in PAO-1, Ps1, Ps2, Ps3, Ps4 and Ps5 ZnO-treated 
isolates respectively (Fig. 4a). Moreover, proteases pro-
duction was significantly decreased to 38%, 52%, 41%, 
33%, 37% and 30% in PAO-1, Ps1, Ps2, Ps3, Ps4 and Ps5 
ZnO-treated isolates respectively (Fig. 4b).
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Figure 4.(a) Elastase production reduction in ZnO-treated isolates. Absorbance at 495 nm was measured to show 
the effect of elastase on ECR after culture of bacteria in LB broth with and without¼ MIC of ZnO for 6 h.(b) 
Proteases production reduction in ZnO-treated bacteria. OD600 was measured following overnight culture of 
bacteria in LB broth with and without¼ MIC of ZnO and incubation of supernatants with skim milk for ½ hr at 
37°C.The data shown are the means ± standard errors of three biological experiments with three technical 
replicates each. *, significant P<0.05. 
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Estimation of  relative gene expression ofQS-regula-
tory genes using qRT-PCR
The relative expression of  the genes regulating virulence 
factors production was assessed in ZnO-treated and un-
treated strains and analyzed using the 2-∆∆Ct method. 
The relative expression levels of  lasI, lasR, rhlI, rhlR, 
pqsA and pqsR were significantly reduced under ZnO-
sub-MIC treatment (Figs. 5a, b, c, d, e and f), respectively. 
5a)


















































































































































































































































African Health Sciences Vol 19 Issue 2, June, 2019 2050
5e)































































































































Figure 5. RT-qPCR showedreduced expressionof (a) lasI, (b) lasR, (c) rhlI, (d) rhlR, (e) pqsA and (f) pqsR in 
ZnO-treated bacteria as compared to untreated ones.The data shown are the means ± standard errors of three 
biological experiments with three technical replicates each. *, significant P< 0.05. 
The relative expression of  lasI gene was significantly de-
creased from 100% in untreated isolates to 69%, 75%, 
40%, 44%, 42% and 36% in PAO-1, Ps1, Ps2, Ps3, Ps4 
and Ps5ZnO-treated isolates respectively, and was also 
reduced to 74%, 49%,60%, 59%, 71% and 51% in PAO-
1, Ps1, Ps2, Ps3, Ps4 and Ps5 ZnO-treated isolates re-
spectivelyfor lasRgene as compared to untreated strains. 
Moreover, the relative expression of  rhlI gene wassig-
nificantly reduced to 5%, 14%, 21%, 14%, 9% and 6% 
in PAO-1, Ps1, Ps2, Ps3, Ps4 and Ps5 ZnO-treated iso-
lates respectively, while rhlR gene relative expression was 
dropped to 8%, 10%, 22%, 8%, 20% and 14% in PAO-1, 
Ps1, Ps2, Ps3, Ps4 and Ps5 ZnO-treated isolates respec-
tively. Furthermore, the relative expression of  pqsA was-
significantly diminished to 22%, 9%, 17%, 10%, 18% and 
21% in PAO-1, Ps1, Ps2, Ps3, Ps4 and Ps5 ZnO-treated 
isolates respectively and the relative expression of  pqsR 
gene was also reduced to 13%, 26%, 31%, 10%, 8% and 
12% in PAO-1, Ps1, Ps2, Ps3, Ps4 and Ps5 ZnO-treated 
isolates respectively.
Specific PCR amplification products of  the tested genes 
lasI, lasR, rhlI, rhlR, pqsA and pqsR were confirmed by 
agarose gel electrophoresis (Figs. 6a, b, c, d, e and f) re-
spectively.
ZnO decreased pathogenesis of  Ps. aeruginosa in vivo
In mice survival test shown in (Fig. 7), mice injected with 
positive control (untreated) Ps. aeruginosa began to die after 
24 h and only 20% of  mice in this group were still alive at 
the end of  the experiment. Importantly, at an infectious 
dose of  approximately 2.5 x 107 CFU, mice injected with 
bacteria treated with ZnO showed a significantly higher 
survival rate as compared to positive control bacteria as 
all mice in this group remained alive at the end of  the 
experiment; a result similar to that of  the negative control 
groups in which no mice in these groups died at the end 
of  the experiment. Our resultssuggest a protective role 
of  ZnO nanoparticles against Ps.aeruginosa pathogenesis 
and virulence in mice.
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Discussion
Ps. aeruginosa has become a principal etiologic agent of  
nosocomial infections which necessitates the urgent and 
efficient application of  proper infection control policies 
to combat its spread. It shows both natural resistance and 
acquired multi-drug resistance to antimicrobial agents by-
differentmechanisms21. As an alternative strategy to anti-
microbial therapy, targeting of  QS has become an attrac-
tive option due to its involvement in regulating virulence 
factors production and pathogenesis in Ps. aeruginosa22.
Anti-virulence therapy (as QS inhibitors) would be valu-
able in the management of  microbial diseases due to the 
lack of  pressures affecting bacterial growth upon using 
anti-virulence agents and so microbial resistance against 
them is not expected18.  
In the present study, ZnO inhibited the growth of  all the 
tested Pseudomonas isolates at 8mg/ml. Testing the ef-
fect of  ¼ MIC of  ZnO nanoparticles(2mg/ml) on mi-
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Figure 6. Agarose gel electrophoresis of (a) lasI amplicon (176bp), (b) lasR amplicon 
(133bp), (c) rhlI amplicon (101bp), (d) rhlR amplicon (160bp), (e) pqsA amplicon 
(74bp) and (f) pqsR amplicon (142bp). All the tested PCR products (amplified genes) 
were detected using 1.5% agarose gel stained with ethidium bromide. Lane 1 (M): 
represent DNA ladder. 
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 Figure 7. Survival rate was significantly reduced in mice injected with untreated 
bacteria in comparison to ZnO-treated bacteria and control groups. Mice survival was 
monitored every day for 3 days and plotted using Kaplan-Meier method. ZnO-treated 
Ps. aeruginosa killed significantly fewer mice as compared to untreated bacteria and 
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cant difference between both ZnO-treated and untreated 
cultures. As a result, any possible effect on QS is not due 
to adverse impact on bacterial viability and growth. In-
stead, it may be attributed to disrupting essential bacterial 
functions. 
Ps. aeruginosa produces an arsenal of  virulence factors 
including pyocyanin, pyoverdin, proteases, elastase and 
rhamnolipids which take partinestablishing infections 
and making the dissemination and invasion of  hosttis-
sues easier23. Recently, nanotechnology has been used to 
develop new nanoparticles that can target QS and viru-
lence factors24-25.
In the current study, ZnO nanoparticles at ¼ MIC 
showed a potent inhibitory effect on the production of-
rhamnolipids,pyocyanin, pyoverdin, hemolysins,elastase 
and proteases. In accordance with our data,Singh et al26 
reported that another type of  metal nanoparticles, silver 
nanoparticles, at sub-MIC exhibited a remarkable reduc-
tion in production of  proteases, elastase, pyocyanin and 
rhamnolipids.
LasI/R and rhlI/R are two principle QS systems that reg-
ulate virulence genes in Ps. aeruginosa. LasI andrhlI syn-
thases are responsible for the production of  C12-AHL 
and C4-AHL autoinducers, respectively. At a threshold 
concentration of  autoinducers, C12-AHL binds with lasR 
and induces the expression of  genes control production 
of  elastase, exotoxin and proteases and also activates the 
rhlI/R system. In addition, C4-AHL binds with rhlR and-
plays role in controlling the expression of  genes encod-
ing production of  elastase, and pyocyanin. IflasI/R and 
rhlI/R are interrupted, virulence factors will be inhibit-
ed27-28.
To further explore the potential quorum quenching effect 
of  ZnO nanoparticles, relative expression of  QS-regulato-
ry genes that controlvirulence factors in Ps. aeruginosa was 
examined using qRT-PCR.Importantly, ZnO nanopar-
ticles significantly down-regulate the relative expression 
of  QS regulatory genes, lasI, lasR, rhlI, rhlR, pqsA and 
pqsRwhich confirm the phenotypic results. Similarly, 
it was proved by Singh et al26 that silver nanoparticles 
down-regulated the expression of  lasI, lasR, rhlI and rhlR 
at the molecular level by inhibiting lasR and rhlR. ZnO 
nanoparticles effect might be similar to that of  silver 
nanoparticles by inhibiting both lasR and rhlR resulting 
in disruption of  QS circuits with subsequent inhibition 
of  virulence factors production. The molecular basis and 
full mechanism of  nanoparticles impact as quorum sens-
ing inhibitor need more investigations in the future.
For more confirmation, the effect of  ZnO nanoparticles 
on Ps. aeruginosa pathogenesis was determined in vivo. In-
terestingly, a significant increase in the survival rate of  
mice injected with ZnO-treated isolates was found in 
comparison to those injected with untreated ones. Pre-
vious reports also showed the protective effect of  QSin-
hibitors against bacterial pathogenesisin mice injected 
with Ps. aeruginosa. This was reported for gingerol19 and 
polyphenolic compounds of  honey29. Our collective phe-
notypic, genotypic and in vivo results strongly potentiate 
the potential use of  ZnO nanoparticles as a powerful QS 
inhibitor in Ps. aeruginosa.
Conclusion
The spread of  MDR strains of  Ps. aeruginosa is of  a partic-
ular concern causing healthcare-associated infections and 
increasing the challenge both in the clinical treatment of  
patients and in the prevention of  the cross-transmission 
of  this problematic pathogen. QS controls the produc-
tion of  many of  virulence factors in Ps. aeruginosa and 
plays an essential role in antimicrobial resistance. ZnO 
nanoparticles is a promising QS inhibitor and anti-viru-
lence compound that can be used as an adjunct for the 
treatment of  Ps. aeruginosa infections such as burns and 
surgical wound infectionsmainly those caused by MDR 
isolates.
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